AMRI to focus on scale and capabilities of API biz following robust 2013
AMRI says it intends to expand its API business to target both generics and more complex molecules after reporting record full year revenue from contract services.
Archives for February 17, 2014
Quintiles reports strong Q4 results, expectations high for 2014
Quintiles reported better-than-expected fourth-quarter results and analysts are predicting strong bookings and improved revenue growth through 2014.
Gold ‘nanoshells’ may offer new delivery option for cancer, hypothermia drugs
A new study published in the Institute of Physics Science reveals that Chinese researchers have developed gold nanoparticles that may help deliver cancer treatments to specifically targeted cells.
breaking news - update 1
Recipharm confirms plans to list on OMX
Recipharm has confirmed that it is making plans to go public this year, citing a desire to finance “rapid growth” and acqusitions as the motivation.
Scinopharm: launches, China and injectables key in FY2014
Sinopharm expects customer drug launches and its recent investment in cancer injectables to drive revenue gains and margin growth in 2014.